http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2365390-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9715ee42ca04792255166d73b4f79385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c108935e8e4bffe53981cc27659352c8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00
filingDate 2007-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61c6f420559b92352158154ff580ea03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8018a7c2f03b9f591f59e5fe3bafea9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8e9bc9e6690d8b3478f8190399a48f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19fb82f884c2df0033e5221950c4f51b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d32f72e0520c26fbf6aa04c4e4b6cbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a0d483c874897942deaaa7c022b4013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3631ea00ac767ddde65af2ac72a90fb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c2d2809d553e649ae957feaeb54726
publicationDate 2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2365390-C2
titleOfInvention Method of bladder neurogenic dysfunction at children treatment
abstract FIELD: medicine. n SUBSTANCE: offered invention concerns medicine area, in particular to urology. High-intensive magnetotherapy by means of AMT-2-AGC apparatus is carried out for treatment of bladder neurogenic dysfunction at children. The patient is exposed to an impulsive magnetic field, 100 msec duration and reaching 500-700 mT amplitude with 0.5 Hz frequency on area of bladder and spinal centres projection, within 6-8-10 minutes, 8-10 daily procedures in a course. n EFFECT: possibility to stop defective emiction syndrome, to restore urodynamics, to extend the remission period accompanying inflammatory diseases of urinary tracts. n 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2564753-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2713816-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2609738-C1
priorityDate 2007-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452080028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422755685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5562578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426120905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414870324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435924

Total number of triples: 42.